Published in Lancet on June 12, 1999
Postdural-puncture headache. Lancet (1999) 0.75
Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev (2008) 2.84
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (2004) 2.44
Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med (1990) 2.42
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst (1997) 2.39
Congenital short colon. World J Surg (1996) 2.31
Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis (2012) 2.20
Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18
Choriocarcinoma and partial hydatidiform moles. Lancet (2000) 2.15
Management of soft-tissue problems in leg trauma in conjunction with application of the Ilizarov fixator assembly. Plast Reconstr Surg (2001) 2.08
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06
Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial. Indian Pediatr (2008) 2.05
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Ann Intern Med (1991) 2.03
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol (1997) 2.00
Management of idiopathic obstruction of the hepatic and suprahepatic inferior vena cava with a self-expanding metallic stent. Cathet Cardiovasc Diagn (1996) 1.99
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (1991) 1.95
Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol (2000) 1.88
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Gestational trophoblastic disease: current management of hydatidiform mole. BMJ (2008) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Gallstone pancreatitis: a prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones. Am J Gastroenterol (1998) 1.77
Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest (1995) 1.75
Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med (1998) 1.74
Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol (1997) 1.71
Medical thoracoscopy for undiagnosed pleural effusions: experience from a tertiary care hospital in north India. Indian J Chest Dis Allied Sci (2011) 1.70
Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70
Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.68
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer (2000) 1.66
Predictors of outcome in emphysematous pyelonephritis. J Urol (1998) 1.62
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J (2007) 1.54
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol (1996) 1.54
Insufficiently active Australian college students: perceived personal, social, and environmental influences. Prev Med (1999) 1.53
Carboplatin or cisplatin? Lancet (1988) 1.53
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol (2006) 1.53
Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum (1997) 1.52
Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst (1997) 1.51
Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol (1998) 1.49
Phase I clinical trial of mitozolomide. Cancer Treat Rep (1985) 1.48
Chemotherapy for ovarian germ cell tumours. Eur J Cancer (1996) 1.48
Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol (1986) 1.48
Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer. BJOG (2014) 1.47
Weaning by gradual pressure support (PS) reduction without an initial spontaneous breathing trial (SBT) versus PS-supported SBT: a pilot study. Rev Port Pneumol (2011) 1.46
Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3'-gallate as the most effective antioxidant constituent. Carcinogenesis (1999) 1.46
Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol (1993) 1.45
An unusual case of mediastinal mass due to Fonsecaea pedrosoi. Eur Respir J (2006) 1.45
A 28-year-old woman with a pulmonary embolus. Lancet (1998) 1.44
A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology (1999) 1.43
Bronchoscopic management of a rare benign endobronchial tumor. Rev Port Pneumol (2012) 1.43
Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2001) 1.42
Percutaneous balloon aortic valvuloplasty during pregnancy: use of the Inoue balloon and the physiologic antegrade approach. Cathet Cardiovasc Diagn (1998) 1.42
Short stature and delayed puberty in gymnasts: influence of selection bias on leg length and the duration of training on trunk length. J Pediatr (2000) 1.41
Chemotherapy of advanced malignant teratomas. Br J Cancer (1980) 1.40
POMB/ACE chemotherapy for mediastinal germ cell tumours. Eur J Cancer (1997) 1.40
Inoue balloon valvuloplasty for the tricuspid valve during pregnancy. Cathet Cardiovasc Diagn (1997) 1.40
Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours. Br J Cancer (1983) 1.40
Current differences in referral patterns for pulmonary endarterectomy in the UK. Eur Respir J (2008) 1.39
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer (1996) 1.38
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours. Ann Oncol (1992) 1.38
Tele-education vs classroom training of neonatal resuscitation: a randomized trial. J Perinatol (2010) 1.37
The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology (2007) 1.37
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney Int (2000) 1.37
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol (1989) 1.35
Management of extensive subcutaneous emphysema and pneumomediastinum by micro-drainage: time for a re-think? Singapore Med J (2007) 1.34
Muscle force measured using "break" testing with a hand-held myometer in normal subjects aged 20 to 69 years. Arch Phys Med Rehabil (2000) 1.34
Epidemiology of fireworks injuries: the National Electronic Injury Surveillance System, 1980-1989. Ann Emerg Med (1994) 1.33
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer (2007) 1.33
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG (2003) 1.32
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer (1979) 1.32
In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs (1997) 1.32
Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol (1995) 1.31
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene (2007) 1.31
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer (1983) 1.31
Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnancies. Int J Gynecol Pathol (2005) 1.30
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci U S A (1999) 1.29
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br J Cancer (1998) 1.29
Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J Clin Microbiol (1999) 1.29
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29
Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci (1998) 1.28
Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev (2004) 1.26
An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene (2011) 1.26
Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J (2010) 1.25
MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene (2010) 1.25
Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology (2005) 1.22
Radiology of gestational trophoblastic neoplasia. Clin Radiol (2006) 1.22
Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res (1996) 1.22
Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway. Oncogene (2008) 1.21
Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J Biol Chem (1992) 1.21
Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology (2001) 1.20